| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0264-410X(01)00014-7 |
| P698 | PubMed publication ID | 11282195 |
| P2093 | author name string | Olsen CW | |
| Larsen DL | |||
| Karasin A | |||
| P2860 | cites work | DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations | Q24563751 |
| Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine | Q24650662 | ||
| Virologic and serologic surveillance for human, swine and avian influenza virus infections among pigs in the north-central United States. | Q30327138 | ||
| Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting | Q33785383 | ||
| Evolution of swine H3N2 influenza viruses in the United States | Q33873666 | ||
| DNA vaccination against influenza viruses: a review with emphasis on equine and swine influenza | Q33912001 | ||
| Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus | Q34070021 | ||
| Fatal swine influenza pneumonia during late pregnancy | Q34181621 | ||
| Long-term maintenance of B cell immunity to influenza virus hemagglutinin in mice following DNA-based immunization | Q34402043 | ||
| Fatal case of swine influenza virus in an immunocompetent host | Q34461070 | ||
| Lack of significant person-to-person spread of swine influenza-like virus following fatal infection in an immunocompromised child | Q45797078 | ||
| Isolation of Swine Influenza Virus from Autopsy Lung Tissue of Man | Q45882200 | ||
| Quantitative detection of porcine interferon-gamma in response to mitogen, superantigen and recall viral antigen | Q48012763 | ||
| DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. | Q52047718 | ||
| Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. | Q52553636 | ||
| Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. | Q54649033 | ||
| Cytotoxic T-cell immunity to influenza. | Q55062679 | ||
| Proved viraemia in asian influenza (Hong Kong variant) during incubation period | Q57116672 | ||
| Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza | Q68621446 | ||
| The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses | Q68948935 | ||
| Protection against papillomavirus with a polynucleotide vaccine | Q70916613 | ||
| Long-Term Anti-Nucleoprotein Cellular and Humoral Immunity Is Induced by Intramuscular Injection of Plasmid DNA Containing NP Gene | Q72100764 | ||
| Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin | Q72603683 | ||
| Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine | Q73091967 | ||
| A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naïve and infection-primed mice | Q73318524 | ||
| Mucosal immunization with DNA encoding influenza hemagglutinin | Q73537528 | ||
| Expression of a viral protein by muscle cells in vivo induces protective cell-mediated immunity | Q73537545 | ||
| DNA vaccination followed by macromolecular multicomponent peptide vaccination against HIV-1 induces strong antigen-specific immunity | Q73619641 | ||
| Heterotypic protection against influenza by immunostimulating complexes is associated with the induction of cross-reactive cytotoxic T lymphocytes | Q74565753 | ||
| Intradermal DNA immunization by using jet-injectors in mice and monkeys | Q74585996 | ||
| HUMAN INFLUENZA INFECTION WITH PROVED VIREMIA. REPORT OF A CASE | Q76531941 | ||
| In vivo gene transfer to skin and wound by microseeding | Q77228564 | ||
| Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS | Q77323993 | ||
| Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boosts | Q77478512 | ||
| Fish farming and influenza pandemics | Q34552859 | ||
| Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses | Q35793550 | ||
| Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin | Q35852069 | ||
| Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery | Q35868177 | ||
| DNA immunization confers protection against murine cytomegalovirus infection | Q35872388 | ||
| Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus | Q36348455 | ||
| Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model | Q36401471 | ||
| Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus | Q37207762 | ||
| Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease | Q37252171 | ||
| Sporadic occurrence of zoonotic swine influenza virus infections | Q37271679 | ||
| DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines | Q37495259 | ||
| Gene transfer into mammalian cells by particle bombardment | Q38568295 | ||
| The prevalence of influenza viruses in swine and the antigenic and genetic relatedness of influenza viruses from man and swine | Q39469331 | ||
| Coadministration of DNA encoding interleukin-6 and hemagglutinin confers protection from influenza virus challenge in mice. | Q39642529 | ||
| Swine Influenza A at Fort Dix, New Jersey (January-February 1976). IV. Summary and Speculation | Q39716868 | ||
| Determinants of immunity to influenza infection in man | Q39784922 | ||
| Dual infections of feeder pigs with porcine reproductive and respiratory syndrome virus followed by porcine respiratory coronavirus or swine influenza virus: a clinical and virological study | Q40672232 | ||
| Systemic and mucosal immune responses to H1N1 influenza virus infection in pigs | Q40766135 | ||
| Effect of intratracheal challenge of fattening pigs previously immunised with an inactivated influenza H1N1 vaccine | Q40810354 | ||
| A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation | Q40818252 | ||
| Superiority of the ear pinna over muscle tissue as site for DNA vaccination | Q40842216 | ||
| Immune responses to nucleic acid vaccines to rabies virus | Q41337967 | ||
| DNA vaccines -- a modern gimmick or a boon to vaccinology? | Q41420498 | ||
| DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors | Q41604739 | ||
| Isolation of swine-like influenza A(H1N1) viruses from man in Switzerland and The Netherlands | Q43209924 | ||
| Transmission of swine influenza virus to humans after exposure to experimentally infected pigs | Q43213541 | ||
| Heterologous protection against influenza by injection of DNA encoding a viral protein | Q43828996 | ||
| Comparison of inactivated, live and recombinant DNA vaccines against influenza virus in a mouse model | Q44285225 | ||
| First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response | Q44570059 | ||
| Swine influenza virus strains recognize sialylsugar chains containing the molecular species of sialic acid predominantly present in the swine tracheal epithelium | Q44597487 | ||
| Protection with split and whole virus vaccines against influenza | Q45017732 | ||
| Genetic characterization of H3N2 influenza viruses isolated from pigs in North America, 1977-1999: evidence for wholly human and reassortant virus genotypes | Q45741176 | ||
| Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen | Q45742861 | ||
| Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models | Q45746483 | ||
| Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in mice | Q45746586 | ||
| Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene | Q45748454 | ||
| Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations | Q45749670 | ||
| IL-6 induces long-term protective immunity against a lethal challenge of influenza virus | Q45750780 | ||
| Enhanced protection against influenza virus of mice immunized as newborns with a mixture of plasmids expressing hemagglutinin and nucleoprotein | Q45754127 | ||
| Interleukin-12 enhances the virus-specific interferon gamma response of pigs to an inactivated pseudorabies virus vaccine | Q45755044 | ||
| Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice | Q45760953 | ||
| Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination | Q45761531 | ||
| DNA immunization against experimental genital herpes simplex virus infection | Q45771376 | ||
| Pathogenicity of a swine influenza H1N1 virus antigenically distinguishable from classical and European strains | Q45774941 | ||
| Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines | Q45783780 | ||
| Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus | Q45788449 | ||
| Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity | Q45795146 | ||
| P433 | issue | 20-22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunization | Q1415366 |
| vaccine | Q134808 | ||
| P304 | page(s) | 2842-2853 | |
| P577 | publication date | 2001-04-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting | |
| P478 | volume | 19 |
| Q30388390 | A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs. |
| Q93085127 | A prime-boost concept using a T-cell epitope-driven DNA vaccine followed by a whole virus vaccine effectively protected pigs in the pandemic H1N1 pig challenge model |
| Q30405461 | An equine herpesvirus 1 (EHV-1) vectored H1 vaccine protects against challenge with swine-origin influenza virus H1N1. |
| Q58706119 | Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses |
| Q30407081 | DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs. |
| Q33208276 | DNA vaccines and their application against parasites--promise, limitations and potential solutions. |
| Q34338715 | Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication |
| Q46060826 | Heterologous prime-boost vaccination with H3N2 influenza viruses of swine favors cross-clade antibody responses and protection. |
| Q51727725 | Non-lethal viral challenge of influenza haemagglutinin and nucleoprotein DNA vaccinated mice results in reduced viral replication. |
| Q45412862 | Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus |
| Q36602277 | Particulate delivery systems for animal vaccines |
| Q39745470 | Preparation and immunological effectiveness of a Swine influenza DNA vaccine encapsulated in PLGA microspheres. |
| Q84980504 | Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles |
| Q33768698 | Prime-boost immunization using a DNA vaccine delivered by attenuated Salmonella enterica serovar typhimurium and a killed vaccine completely protects chickens from H5N1 highly pathogenic avian influenza virus |
| Q80462048 | Priming with DNA vaccine and boosting with killed vaccine conferring protection of chickens against infectious bursal disease |
| Q45377413 | Priming with a DNA vaccine and boosting with an inactivated vaccine enhance the immune response against infectious bronchitis virus |
| Q45387769 | Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus |
| Q33569057 | Protection of chicken against very virulent IBDV provided by in ovo priming with DNA vaccine and boosting with killed vaccine and the adjuvant effects of plasmid-encoded chicken interleukin-2 and interferon-gamma |
| Q39545747 | Protection of chickens against infectious bronchitis virus with a multivalent DNA vaccine and boosting with an inactivated vaccine |
| Q45600695 | Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus |
| Q47295709 | Protective effect of a polyvalent influenza DNA vaccine in pigs |
| Q30418612 | Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin |
| Q30426110 | Recombinant equine herpesvirus 1 (EHV-1) vaccine protects pigs against challenge with influenza A(H1N1)pmd09. |
| Q47153755 | Scientific opinion on the possible risks posed by the influenza A (H3N2v) virus for animal health and its potential spread and implications for animal and human health |
| Q41169554 | Vaccination-challenge studies with a Port Chalmers/73 (H3N2)-based swine influenza virus vaccine: Reflections on vaccine strain updates and on the vaccine potency test |
| Q30424943 | Vaccine development for protecting swine against influenza virus |
| Q38401954 | Vaccines against influenza A viruses in poultry and swine: Status and future developments |
Search more.